Soluble TNF-α receptors bind and neutralize over-expressed transmembrane TNF-α on macrophages, but do not inhibit its processing

Journal of Leukocyte Biology

Volumn 66, Issue 6, 1999, Pages 1005-1013

  Watts, Alan D ^b   Hunt, Nicholas H ^b   Madigan, Michele C ^b   Chaudhri, Geeta ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE

Author keywords

Cell surface TNF ; Cytokine; Cytotoxicity; TACE inhibitor TNF bp

Indexed keywords

MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

EID: 0033404614     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.66.6.1005     Document Type: Article

References (51)

1. Kriegler, M., Perez, C., DeFay, K., Albert, I., Lu, S. D. (1988) A novel form of TNF-α/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF-α. Cell 53, 45-53.
2. Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L., Kriegler, M. (1990) A nonsecretable cell surface mutant of tumor necrosis factor (TNF-α) kills by cell-to-cell contact. Cell 63, 251-258.
3. Decoster, E., Vanhaesebroeck, B., Vandenabeele, P., Grooten, J., Fiers, W. (1995) (Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor. J. Biol. Chem. 270, 18473-18478.
4. Tang, P., Hung, M. C., Klostergaard, J. (1996) Human pro-tumor necrosis factor is a homotrimer. Biochemistry 35, 8216-8225.
5. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370, 555-557.
6. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J. M., Crimmin, M., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., et al. (1995) Matrix metalloproteinases and processing of pro-TNF-alpha. [Review]. J. Leukoc. Biol. 57, 774-777.
7. McGeehan, G. M., Becherer, J. D., Bast, R. C. J., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., et al. (1994) Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370, 558-561.
8. Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torrance, D. S., Otten, E. C., Greenstreet, T., Weerawarna, K., et al. (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370, 218-220.
9. Black, K. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. K. Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J., Cerretti, D. P. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729-733.
10. Moss, M. L., Jin, S. L. C., Milla, M. K., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. H., Leesnitzer, M. A., McCauley, P., McGeehan, C., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J. L., Warner, J., Willard, D., et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733-736.
11. Buxbaum, J. D., Liu, K. N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., Black, R. A. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767.
12. Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., Boyce, R. W., Nelson, N., Kozlosky, C. J., Wolfson, M. F., Rauch, C. T., Cerretti, D. P., Paxton, R. J., March, C. J., Black, R. A. (1998) An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284.
13. Grell, M., Douni, E., Wajunt, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., Scheurich, P. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80-kDa tumour necrosis factor receptor. Cell 83, 793-802.
14. Hale, K. K., Smith, C. G., Baker, S. L. Vanderslice, R. W., Squires, C. H., Gleason, T. M., Tucker, K. K., Kohno, T., Russell, D. A. (1995) Multifunctional regulation of the biological effects of TNF-α by the soluble type I and type II TNF-α receptors. Cytokine 7, 26-38.
15. Scallon, B. J., Trinh, H., Nedelman, M., Brennan, F. M., Feklmann, M., Ghrayeb, J. (1995) Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins. Cytokine 7, 759-770.
16. Peetre, C., Thysell, H., Grubb, A., Olsson, I. (1988) A tumor necrosis factor binding protein is present in human biological fluids. Eur. J. Haematol. 41, 414-419.
17. Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., Widmer, M. B., Blosch, C. M. (1997) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337, 141-147.
18. Evans, T. J., Moyes, D., Carpenter, A., Martin, R., Loetscher, H., Lesslauer, W., Cohen, J. (1994) Protective effect of 55-but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis. J. Exp. Med. 180, 2173-2179.
19. Terlizzese, M., Simoni, P., Antonetti, F. (1996) In vitro comparison of inhibiting ability of soluble TNF-α receptor p75 (TBP II) vs. soluble TNF-α receptor p55 (TBP I) against TNF-α and TNF-β. J. Interferon Cytokine Res. 16, 1047-1053.
20. Norman, J. G., Fink, G. W., Messina, J., Carter, G., Franz, M. G. (1996) Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 120, 515-521.
21. Espat, N. J., Cendan, J. C., Beierle, E. A., Auffenberg, T. A., Rosenberg, J., Russell, D., Kenney, J. S., Fischer, E., Montegut, W., Lowry, S. F., Copeland, E. M., Moldawer, L. L. (1995) PEG-bp-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock. J. Surg. Res. 59, 153-158.
22. Burger, D., Kieft, G., Seely, J., Dayer, J. M., Edwards, C. K. (1996) Inhibition of proinflammatory factor production by fibroblast-like cells with TNE-α-binding protein [TNF-α-bp] In First Joint Meeting of the International Cytokine Society and the International Society for Interferon and Cytokine Research. 7, 561.
23. Lucas, R., Lou, J. N., Juillard, P., Moore, M., Bluethmann, H., Grau, G. E. (1997) Respective role of TNF-α receptors in the development of experimental cerebral malaria. J. Neuroimmunol. 72, 143-148.
24. Georgopoulos, S., Plows, D., Kollias, G. (1996) Transmembrane TNF-α is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J. Inflamm. 46, 86-97.
25. De, A. K., Kodys, K., Puyana, J. C., Fudem, G., Savoie, P., Millergraziano, C. L. (1995) Elevated IL-8 production by trauma patients monocytes is associated with elevated secretion of TNF-alpha. Shock 4, 171-177.
26. Crowe, P. D., VanArsdale, T. L., Walter, B. N., Ware, C. F., Hession, C., Ehrenfels, R., Browning, J. L., Din, W. S., Goodwill, R. G., Smith, C. A. (1994) A lymphotoxin-beta-specific receptor [see comments]. Science 264, 707-710.
27. Ziegler-Heitbrock, H. W. L., Thiel, E., Futterer, A., Herzog, V., Wirtz, A., Riethmuller, G. (1988) Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 41, 456-461.
28. Pradines-Figueres, A., Raetz, C., K. (1992) Processing and secretion of tumor necrosis factor alpha in endotoxin-treated Mono Mac 6 cells are dependent on phorbol myristate acetate. J. Biol. Chem. 267, 23261-23268.
29. Watts, A. D., Hunt, N. H., Hambly, B. D., Chaudhri, G. (1997) Separation of tumor necrosis factor a isoforms by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 18, 1086-1091.
30. Espevik, T., Nissen, M. J. (1986) A highly sensitive cell line, WKHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Meth. 95, 99-105.
31. Fishman, M., Gunther, G. (1986) Induction of tumor cell resistance to macrophage-mediated lysis by phorbol esters: a postbinding event. Cell. Immunol. 100, 374-388.
32. Gavrieli, Y., Sherman, Y., Ben-Sasson, S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
33. Jue, D.-M., Sherry, B., Luedke, C., Manogue, K. R., Cerami, A. (1990) Processing of newly synthesised cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry 29, 8371-8377.
34. Sherry, B., Jue, D.-M., Zentella, A., Cerami, A. (1990) Characterization of high molecular weight glycosylated forms of murine tumor necrosis factor. Biochem. Biophys. Res. Commun. 173, 1072-1078.
35. de Kossodo, S., Houba, V., Grau, G. E., Waage, A., Meager, A., Kramer, S. M., Yamazaki, S., Kwiatkowski, D., Lamche, H., Kleinhammer, G., Eberle, W., Vandermeer, J., Buurman, W., Teppo, A. M., Stephens, S. (1995) Assaying tumor necrosis factor concentrations in human serum - a WHO international collaborative study. J. Immunol. Meth. 182, 107-114.
36. Watts, A. D., Onier-Cherix, N., Hunt, N. H., Chaudhri, G. (1999) Use of fixed cells in cell contact-dependent cytotoxicity assays for TNF-α: A cautionary report. J. Immunol. Meth., in press.
37. Beyaert, R., Fiers, W. (1994) Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. [Review]. FEBS Lett. 340, 9-16.
38. Kerr, J. F. Wyllie, A. H., Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
39. Browning, J., Ribolini, A. (1989) Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines. J. Immunol. 143, 1859-1867.
40. Branch, D. R., Guilbert, L. J. (1996) Differential expression of tumor necrosis factor-α isoforms from lipopolysaccharide- and cytokine-stimulated mouse macrophages. Int. J. Biochem. Cell Biol. 28, 949-955.
41. Watts, A. D., Hunt, N. H., Wanigasekera, Y., Bloomfield, G., Wallach, D., Roufogalis, B. D., Chaudhri, G. (1999) A casein kinase I motif present in the cytoplasmic domain of most members of the TNF-α ligand family is implicated in "reverse signaling". EMBO J. 18, 2119-2126.
42. Wiley, S. R., Goodwin, R. G., Smith, C. A. (1996) Reverse signaling via CD30 ligand. J. Immunol. 157. 335-3639.
43. van Essen, D., Kikutani, H., Gray, D. (1995) CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378, 620-623.
44. Stuber, E., Neurath, M., Calderhead, D., Fell, H. E., Strober, W. (1995) Cross-linking of OX40 ligand, a memher of the TNF-α/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2, 507-521.
45. Higuchi, M., Nagasawa, K., Horiuchi, T., Oike, M., Ito, Y., Yasukawa, M., Niho, V. (1997) Membrane tumor necrosis factor-alpha (TNF-α) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation-characterization of membrane TNK-α. Clin. Immunol. Immunopathol. 82, 133-140.
46. Clements, J. M., Cossins, J. A., Wells, G. M., Corkill, D. J., Helfrich, K., Wood, L. M., Pigott, R., Stabler, G., Ward, G. A., Gearing, A. J., Miller, K. M. (1997) Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J. Neuroimmunol. 74, 85-94.
47. DiMartino, M., Wolff, C., High, W., Stroup, G., Hoffman, S., Laydon, J., Lee, J. C., Bertolini, D., Galloway, W. A., Grimmin, M. J., Davis, M., Davies, S. (1997) Anti-arthritic activity of hydroxamic acid-based pseudopeptide inhibitors of matrix metalloproteinases and TNF-α processing. Inflamm. Res. 46, 211-215.
48. Growe, P. D., Walter, B. N., Mohler, K. M., Otten-Evans, C., Black, R. A., Ware, G. F. (1995) A metalloprotease inhibitor blocks shedding of the 80-kD TNF-α receptor and TNF-α processing in T lymphocytes. J. Exp. Med. 181, 1205-1210.
49. Higuchi, M., Aggarwal, B. B. (1994) Differential roles of two types of the TNF-α receptor in TNF-α-induced cytotoxicity, DNA fragmentation, and differentiation. J. Immunol. 152, 4017-1025.
50. Eissner, G., Kohlhuber, F., Grell, M., Ueffing, M., Scheurich, P., Hieke, A., Multhoff, G., Bornkamm, G. W., Holler, K. (1995) Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 86, 4184-4193.
51. Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K., Yagita, H. (1995) Metalloproteinase-mediated release of human fas ligand. J. Exp. Med. 182, 1777-1783.